Assembly and release of SIV Env proteins with full-length or truncated cytoplasmic domains

Virology

Volumn 221, Issue 1, 1996, Pages 22-33

  Vzorov, Andrei N ^a   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL LINE; COMPLEX FORMATION; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINIA VIRUS; VIRUS ASSEMBLY; VIRUS PARTICLE; VIRUS RECOMBINANT;

EID: 0030199246     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0349     Document Type: Article

References (42)

1. Allan, J S., Whitehead, E. M., Strout, K., Short, M., Kanda, P., Hart, T. K., and Bugelski, P. J. (1992). Strong association of SIVagm envelope glycoprotein heterodimers: Possible role in receptor-mediated activation. AIDS Res. Hum. Retroviruses 8, 2011-2020.
2. Ashorn, P. A., Berger, E. A., and Moss, B. (1990). Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64, 2149-2156.
3. Chakrabarti, S., Brechung, K., and Moss, B. (1988). Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5, 3403-3409.
4. Chakrabarti, L., Emerman, M., Tiollais, P., and Sonigo, P. (1989). The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity. J. Virol. 63, 4395-4403.
5. Dorfman, T., Mammano, R., Haseltine, W. A., and Gottlingers, H. G. (1994). Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68, 1689-1696.
6. Dubay, J. W., Dubay, S. R., Shin, H. J., and Hunter, E. (1995). Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: Requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 69, 4675-4682.
7. Freed, E. O., and Martin, M. A. (1995). Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69(3), 1984-1989.
8. + T lymphocytes. J. Virol. 66, 6489-6495.
9. Gebhardt, A., Bosch, J. V., Zemiecki, A., and Friis, R. R. (1984). Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. J. Mol. Biol. 174, 297-317.
10. Gendelman, H. E., Orenstein, J. M., Baca, L. M., Weiser, B., Burger, H., Kalter, D. C., and Meltzer, M. S. (1989). The macrophage in the persistence and pathogenesis of HIV infection. AIDS 3, 475-495.
11. Gheysen, D., Jacobs, E., de Foresta, F., Thiriart, C., Francotte, M., Thines, D., and De Wilde, M. (1989). Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59, 103-112.
12. Haffar, O., Garrigues, J., Travis, B., Moran, P., Zarling, J., and Hu, S.-L. (1990). Human immunodeficiency virus-like, non-replicating Gag-Env particles assemble in a recombinant vaccinia virus expression system. J. Virol. 64, 2653-2659.
13. Henderson, L. E., Sowder, R. C., Copeland, T. D., Oroszlan, S., and Benveniste, R. E. (1990). Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions. J. Med. Primatol. 19, 411-419.
14. Hu, S.-L., Travis, B. M., Garrigues, J., Zarling, J. M., Sridhar, P., Dykers, T., Eichberg, J. W., and Alpers, C. (1990). Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus. Virology 179, 321-329.
15. Johnston, P. B., Dubay, J. W., and Hunter, E. (1993). Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol. 67, 3077-3086.
16. Jones, L. V., Compans, R. W., Davis, A. R., Bos, T. J., and Nayak, D. P. (1985). Surface expression of the influenza neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells. Mol. Cell. Biol. 5, 2181-2189.
17. Jones, T. A., Blaug, G., Hansen, M., and Barklis, E. (1990). Assembly of gag-β-galactosidase proteins into retrovirus particles. J. Virol. 64, 2265-2279.
18. Karacostas, V., Nagashima, K., Gonda, M. A., and Moss, B. (1989). Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86, 8964-8967.
19. Klatzmann, D., Barre-Sinoussi, F., Nugeyre, M. T., Dauget, C., Vilmer, E., Grisceli, C., Brun-Vezinet, F., Rouzioux, C., Gluckman, J. C., Chermann, J.-C., and Montagnier, L. (1984). Selective tropism of lymphadenopathy associated virus (LAV) for helper-induced T lymphocytes. Science 225, 59-63.
20. Kodama, T., Wooley, D. P., Naidu, Y. M., Kestler, H. W., Daniel, M. D., Li, Y., and Desrosiers, R. C. (1989). Significance of premature stop codons in env of simian immunodeficiency virus. J. Virol. 63, 4709-4714.
21. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 277, 680-685.
22. Layne, S. P., Merges, M. J., Dembo, M., Spouge, J. L., Conley, S. R., Moore, J. P., Raina, J. L., Renz, H., Gelderblom, H. R., and Nara, P. L. (1992). Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189, 695-714.
23. Mackett, M., Smith, G. L., and Moss, B. (1985). The construction and characterization of vaccinia virus recombinants expressing foreign genes. In "DNA Cloning" (D. M. Glover, Ed.), pp. 191-212. IRL Press, Oxford/New York.
24. Mulligan, M. J., Kumar, P., Hui, H., Owens, R. J., Ritter, G. D., Hahn, B. H., and Compans, R. W. (1990). The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation. AIDS Res. Hum. Retroviruses 6, 707-720.
25. Mulligan, M. J., Yamshchikov, G. V., Ritter, G. D. J., Gao, F., Jn, M. J., Nail, C. D., Hahn, B. H., and Compans, R. W. (1992). Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Wol. 66, 3971-3975.
26. Owens, R. J., and Compans, R. W. (1989). Expression of the HIV envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J. Wol. 63, 978-982.
27. Owens, R. J., Dubay, J., Hunter, E., and Compans, R. W. (1991). The human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc. Natl. Acad. Sci. USA 88, 3987-3991.
28. Owens, R. J., Burke, C., and Rose, J. K. (1994). Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity. J. Wol. 68, 570-574.
29. Regier, D. A., and Desrosiers, R. C. (1990). The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 6, 1221-1231.
30. Rhodes, A. D., Spitali, M., Hutchinson, G., Rud, E. W., and Stephens, P. E. (1994). Expression, characterization and purification of simian immunodeficiency virus soluble, oligomerized gp160 from mammalian cells. J. Gen. Wol. 75, 207-213.
31. Rtter, G. D., Mulligan, M. J., and Compans, R. W. (1993). Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology 197, 255-264.
32. Rolls, M. M., Webster, P., Balba, N. H., and Rose, J. K. (1994). Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 79, 497-506.
33. Roth, M. G., Compans, R. W., Giusti, L., Davis, A. R., Nayak, D. P., Gething, M. J., and Sambrook, J. (1983). Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell 33, 435-442.
34. Salzwedel, K., Johnson, P. B., Roberts, S. J., Dubay, J. W., and Hunter, E. (1993). Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J. Wol. 67, 5279-5288.
35. Shioda, T., and Shibota, H. (1990). Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology 175, 139-148.
36. Smith, A. J., Cho, M.-J., Hammarskjold, M.-L., and Rekosh, D. (1990). Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles. J. Wol. 64, 2743-2750.
37. Spies, C. P., and Compans, R. W. (1994). Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein. Virology 203, 8-19.
38. Vzorov, A. N., Bukrinsky, M. I., Grigoryev, V. B., Tentsov, Y. Y., and Bukrinskaya, A. G. (1991). Highly immunogenic HIV-like particles deprived of virus specific RNA are produced by recombinant vaccinia virus infected cells. AIDS Res. Hum. Retroviruses 7, 29-36.
39. Yang, C., Spies, C. P., and Compans, R. W. (1995). The human and simian immunodeficiency virus envelope glycoprotein transmembrane sub-units are palmitoylated. Proc. Natl. Acad. Sci. USA 92, 9871-9875.
40. Yu, X., Yuan, X., Matsuda, Z., Lee, T.-H., and Essex, M. (1992). The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virus. J. Virol. 66, 4966-4971.
41. Yu, X., Yuan, X., McLane, M. F., Lee, T. H., and Essex, M. (1993). Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions. J. Virol. 67, 213-221.
42. Zingler, K., and Littman, D. R. (1993). Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into particles and fusogenicity and infectivity. J. Virol. 67, 2824-2831.